Sang Eon Park

7PUBLICATIONS
17CO-AUTHORS
Liquid biopsiesChemotherapyMolecular targetsRegenerative medicine (incl. stem cells)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 08, 2025
Safety and Tolerability of Wharton's Jelly-Derived Mesenchymal Stem Cells for Patients With Duchenne Muscular Dystrophy: A Phase 1 Clinical Study.

Jiwon Lee, Sang Eon Park, Mira Kim

|Oct 12, 2023
Nervonic Acid Inhibits Replicative Senescence of Human Wharton's Jelly-Derived Mesenchymal Stem Cells.

Sun Jeong Kim, Soojin Kwon, Soobeen Chung

|Aug 26, 2022
A New Method of Myostatin Inhibition in Mice via Oral Administration of Lactobacillus casei Expressing Modified Myostatin Protein, BLS-M22.

Dong Kyung Sung, Hyeongseop Kim, Sang Eon Park

|Apr 22, 2022
Wharton's Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic Potential.

Sun Jeong Kim, Sang Eon Park, Jang Bin Jeong

|Sep 28, 2021
Wharton's Jelly-Derived Mesenchymal Stem Cells Reduce Fibrosis in a Mouse Model of Duchenne Muscular Dystrophy by Upregulating microRNA 499.

Sang Eon Park, Jang Bin Jeong, Shin Ji Oh

|Sep 30, 2020
Pressure Stimuli Improve the Proliferation of Wharton's Jelly-Derived Mesenchymal Stem Cells under Hypoxic Culture Conditions.

Sang Eon Park, Hyeongseop Kim, Soojin Kwon

Pageof 2

Frequent Collaborators

3 joint publications

Hyeongseop Kim

3 joint publications

Sun Jeong Kim

3 joint publications

Hong Bae Jeon

3 joint publications

Jong Wook Chang